Alamar Biosciences Stock

alamarbio.comHealthcareFounded: 2018Funding to Date: $120.3MM

Alamar biosciences developing medical platforms in the field of proteomics to enable the early detection of cancer and other diseases.

Register for Details

For more details on financing and valuation for Alamar Biosciences, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Alamar Biosciences.

Register Today

Other companies like Alamar Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

The companies aim to bring together Alamar's immunoassay-based NULISA proteomics platform and Abcam's extensive antibody portfolio.